drugset / Trial / NCT02538484

Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects

NCT02538484

RandomizedParallel-groupOpen-labelBasic science

Summary

Assess the impact of dietary omega 3 free fatty acids and/or letrozole on obese, postmenopausal breast cancer patients.

Timeline

Start
2016-04
Primary completion
2020-03-11
Completion
2020-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Fish oil Other / unclassified 2700 mg Oral
Comparator Letrozole Other / unclassified 2.5 mg Oral

Indications